Related Experiment Video
Updated: Aug 8, 2026
06:09
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
Published on: June 22, 2016
Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia
F Vuillier1, K Maloum, E K Thomas
1Unité d'Immuno-Hématologie et d'Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, F-75724 Paris Cedex 15, France. vuillier@pasteur.fr
British Journal of Haematology
|February 15, 2002
Summary
Generating functional dendritic cells (DCs) from chronic lymphocytic leukemia (CLL) patients is possible. These CLL-derived DCs show similar function to normal DCs, offering potential for new cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Chronic lymphocytic leukemia (CLL) is an incurable B-cell malignancy with high relapse rates despite current treatments.
- Novel therapeutic strategies are needed to enhance anti-leukemia immune responses, particularly cytotoxic T lymphocytes (CTLs).
- Challenges exist in generating effective anti-tumor T cells in CLL due to B-cell characteristics and potential T-cell dysfunction.
Purpose of the Study:
- To investigate the feasibility of generating functional dendritic cells (DCs) from monocytes of CLL patients.
- To compare the phenotype and function of CLL-derived DCs with those from healthy donors.
- To identify factors influencing DC maturation and cytokine production in CLL.
Main Methods:
- Monocytes were isolated from CLL patients and normal donors.
- Monocytes were differentiated into DCs using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 in serum-free medium.
- Morphological, phenotypic, and functional characteristics of the generated DCs were analyzed.
- Cytokine production (IL-10, IL-12, IL-15) was assessed under various stimulation conditions (IFN-gamma, CD40L).
Main Results:
- Functional DCs with similar phenotypes and functions to those from normal donors can be generated from CLL patients.
- Monocyte-derived DCs from CLL patients spontaneously secrete endogenous IL-10, unlike controls.
- Interferon (IFN)-gamma and CD40L are crucial for priming CLL-derived DCs to produce IL-12 and IL-15.
Conclusions:
- Functionally competent dendritic cells can be derived from circulating monocytes in CLL patients.
- These findings support the potential of using autologous CLL-derived DCs for immunotherapy strategies.
- Further research into optimizing DC-based therapies for CLL is warranted.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...